Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatmen... ( Lilly Studies Predictive Factors to...)

Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes

Date:9/25/2007

Lilly Studies Predictive Factors to Better Target Patients for ALIMTA(R) (pemetrexed for injection) in the Treatment of Non-Small Cell Lung Cancer

BARCELONA, Spain, Sept. 25 /PRNewswire-FirstCall/ -- In clinical research, patients with advanced non-small cell lung cancer (NSCLC) that are classified as having a non-squamous histology achieve statistically significant higher survival when treated in the second-line setting with ALIMTA(R) (pemetrexed for injection) when compared to histologically-similar patients treated with docetaxel. The data (ECCO Abstract # 6521)(1) were presented at the 14th European Cancer Conference (ECCO) in Barcelona. ALIMTA, manufactured and marketed by Eli Lilly and Company, is currently indicated for the second-line treatment of advanced NSCLC in more than 85 countries.

The retrospective analysis of Phase III data(2) consisted of 571 patients. The analysis showed that non-squamous patients treated with ALIMTA achieved a statistically higher overall survival compared to those treated with docetaxel (9.3 months and 8.0 months, respectively; hazard ratio 0.778 [95% CI 0.607- 0.997]). Conversely, the analysis suggested that patients with a squamous histology and treated with docetaxel had a statistically higher overall survival compared to those treated with ALIMTA (7.4 months and 6.2 months respectively; hazard ratio 1.563 [95% CI 1.079, 2.264]). Patients with a non- squamous histology represented the majority of the patients on the trial.

The retrospective analysis was driven by preclinical data that suggested patients with a lower expression of thymidylate synthase (TS) enzyme show an increased efficacy when treated with ALIMTA.(3,4) The histological type of NSCLC is determined by how the cancerous cells appear under a microscope. Two of the most common histological types of NSCLC are adenocarcinoma and large cell carcinoma (5) and constitute approximately 55 percent of all NSCLC diagnoses.(6) These two subgroups, a
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
4. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
5. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
8. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
9. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
10. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
11. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis

Post Your Comments:

(Date:5/22/2013)... , May 22, 2013 Advanced Prenatal ... medical device that will help alleviate the high blood ... apheresis cartridge is expected to be the first medical ... of maternal and fetal death. Every year, ... the United States . It is characterized by ...

(Date:5/22/2013)... , May 22, 2013 Attorney ... potential claims on behalf of purchasers of the ... "Company") (NasdaqGS: AMAG -News). The investigation focuses on ... securities laws. On May 22, 2013, ... intraday trading after the company announced in regulatory ...

(Date:5/22/2013)... May 22, 2013 The Leukemia & Lymphoma Society ... Valor Biotherapeutics, LLC, a joint venture between ImmunGene and ... and a Phase I clinical trial for a novel ... by many patients with indolent lymphomas who do not ... Valor,s protein, IGN002, is a new class of biotherapeutics ...

Breaking Medicine Technology:Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4

[0] Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia [0] Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc.[0] The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients

... Yesterday, T he Lancet published online the ... Victoza® (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia®. The 26-week ... plasma glucose (FPG), and body weight than Januvia®, with similar or ... , , ...

... April 23 Results of a ... g/d significantly improved lipid and glycemic measures in ... fasting glucose and/or impaired glucose tolerance). The randomized, ... American Association of Clinical Endocrinologists (AACE) 19th Annual ...

The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes

(Date:5/23/2013)... (PRWEB) May 23, 2013 As Stryker ... Rejuvenate and ABG II Modular-Neck Hip Stems continue to mount ... new research has found a connection between the type of ... The study, which was published on May 15th in ... hips in 11 patients who reported new-onset and increasing ...

(Date:5/23/2013)... (PRWEB) May 23, 2013 Diabetes is ... it can become a nuisance when patients are unfortunate ... According to the National Diabetes Information Clearinghouse at ... at a risk of developing neuropathy which further shrivels ... lives of such patients. Such nerve damage affects the ...

(Date:5/23/2013)... SLEEPY HOLLOW, NY (PRWEB) May 23, 2013 ... joined the staff of Phelps Memorial Hospital Center as ... She will direct comprehensive inpatient and outpatient rehabilitation ... life. , Dr. Liu received her undergraduate degree in ... Scholar for four years. She earned her medical ...

(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Statins are proven ... the medications also could hamper heart patients, ability to ... A small group of overweight or obese people were ... a 40 milligram daily dose of simvastatin, while another ... exercise regimen did show improvement, found the study released ...

(Date:5/23/2013)... (May 23, 2013) -- Little is known about why ... response to treatments varies between patients. Now, a team ... Medical Center and SUNY Downstate Medical Center has revealed ... showing that it is very different from other asthma ... , reveals that an over-active gene linked in 20 ...

Breaking Medicine News(10 mins):Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 2 Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 3 Health News:Neuropathy Nerve Damage Can Now Be Reversed With Neuracel 2 Health News:Wei Angela Liu, MD, Named Head of Physical Medicine and Rehabilitation at Phelps Memorial Hospital Center in Sleepy Hollow, New York 2 Health News:Statins May Hamper Workout Results 2 Health News:Statins May Hamper Workout Results 3 Health News:Researchers find common childhood asthma unconnected to allergens or inflammation 2 Health News:Researchers find common childhood asthma unconnected to allergens or inflammation 3

[0] Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction [0] Neuropathy Nerve Damage Can Now Be Reversed With Neuracel [0] Wei Angela Liu, MD, Named Head of Physical Medicine and Rehabilitation at Phelps Memorial Hospital Center in Sleepy Hollow, New York [0] Statins May Hamper Workout Results [0] Researchers find common childhood asthma unconnected to allergens or inflammation

... Johna Burke will describe communication tactics that can ... delivered on Tuesday, Jan. 6, at a professional ... of the International Association of Business Communicators (IABC). ... website ( www.sc-iabc.com ) or from Stefanie Caraviello ...

... Care Action Network (SCAN(R)) Health Plan Arizona, a nonprofit Medicare ... to train more than 60 seasoned van drivers about what ... a senior." SCAN has been focused on the unique needs ... to enhancing awareness and skills in the community in dealing ...

... Calif., January 5, 2008Scientists at Burnham Institute for Medical ... protein kinase complex Cdc7/Dbf4 or Cdc7/Drf1 (Ddk) in monitoring ... DNA repair. Since Ddk is often deregulated in human ... damage control could help shape new cancer therapies. The ...

... 5, 2009 Only 17 percent of Spanish-speaking women ... a multivitamin containing folic acid daily, according to the ... on this population. , Folic acid can prevent ... brain and spine such as spina bifida and anencephaly, ...

... experts at the University of Cincinnati (UC) have identified a ... drug therapies to combat lung cancer. , The study, led ... of Molecular and Cellular Biology . , Proto-oncogenes ... (turnover of cells and tissue) but, when genetically modified, can ...

... ignition gadget prevents calls or texting while driving , , ... that prevents teens from talking on cell phones or ... of Utah researchers. , The Key2SafeDriving system includes ... connects wirelessly with the user,s cell phone via either ...

Cached Medicine News:Health News:South Carolina IABC Event to Hear from BurrellesLuce Exec on Best Ways to Reach Multi-Generation Audience 2 Health News:South Carolina IABC Event to Hear from BurrellesLuce Exec on Best Ways to Reach Multi-Generation Audience 3 Health News:SCAN Health Plan Arizona Helps Drivers Understand the Challenges of Aging 2 Health News:SCAN Health Plan Arizona Helps Drivers Understand the Challenges of Aging 3 Health News:Burnham researchers illuminate mechanisms that regulate DNA damage control and replication 2 Health News:Folic acid survey of Spanish-speaking women finds most are missing benefits, March of Dimes says 2 Health News:Cell biologists identify new tumor suppressor for lung cancer 2 Health News:Car Key Device Jams Teens' Cell Phones 2

South Carolina IABC Event to Hear from BurrellesLuce Exec on Best Ways to Reach Multi-Generation Audience SCAN Health Plan Arizona Helps Drivers Understand the Challenges of Aging Burnham researchers illuminate mechanisms that regulate DNA damage control and replication Folic acid survey of Spanish-speaking women finds most are missing benefits, March of Dimes says Cell biologists identify new tumor suppressor for lung cancer Car Key Device Jams Teens' Cell Phones

Mx3000P instrument, desktop computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, HE...

Inquire...

... real-time PCR detection system offers an affordable ... fluorescent dyes such as FAM and SYBR ... the iCycler thermal cycler, offering superior features ... performance. The MyiQ real-time PCR detection system ...

... PRISM 7000 Sequence Detection System is ... detects and quantitates nucleic acid sequences. ... accumulated PCR product is made possible ... and application-specific software in a single ...

Medicine Products:

Mx3000P Real-Time PCR System (110 volt) with Desktop Computer Mx3000P Real-Time PCR System (110 volt) with Notebook Computer MyiQ Single-Color Real-Time PCR Detection System ABI Prism 7000 Sequence Detection System with Notebook Computer